Climate Change Data Portal
DOI | 10.1016/j.yrtph.2016.01.007 |
Adverse outcome pathways: From research to regulation scientific workshop report | |
Kleinstreuer, Nicole C.1; Sullivan, Kristie2; Allen, David3; Edwards, Stephen4; Mendrick, Donna L.5; Embry, Michelle6; Matheson, Joanna7; Rowlands, J. Craig8; Munn, Sharon9; Maull, Elizabeth1; Casey, Warren1 | |
发表日期 | 2016-04-01 |
ISSN | 0273-2300 |
卷号 | 76页码:39-50 |
英文摘要 | An adverse outcome pathway (AOP) helps to organize existing knowledge on chemical mode of action, starting with a molecular initiating event such as receptor binding, continuing through key events, and ending with an adverse outcome such as reproductive impairment. AOPs can help identify knowledge gaps where more research is needed to understand the underlying mechanisms, aid in chemical hazard characterization, and guide the development of new testing approaches that use fewer or no animals. A September 2014 workshop in Bethesda, Maryland considered how the AOP concept could improve regulatory assessments of chemical toxicity. Scientists from 21 countries, representing industry, academia, regulatory agencies, and special interest groups, attended the workshop, titled Adverse Outcome Pathways: From Research to Regulation. Workshop plenary presentations were followed by breakout sessions that considered regulatory acceptance of AOPs and AOP-based tools, criteria for building confidence in an AOP for regulatory use, and requirements to build quantitative AOPs and AOP networks. Discussions during the closing session emphasized a need to increase transparent and inclusive collaboration, especially with disciplines outside of toxicology. Additionally, to increase impact, working groups should be established to systematically prioritize and develop AOPs. Multiple collaborative projects and follow-up activities resulted from the workshop. (C) 2016 Elsevier Inc. All rights reserved. |
英文关键词 | AOP;Workshop;Toxicology;Pathway;Regulatory;Quantitative;Application;Acceptance;Criteria;Computational |
语种 | 英语 |
WOS记录号 | WOS:000375514200005 |
来源期刊 | REGULATORY TOXICOLOGY AND PHARMACOLOGY |
来源机构 | 美国环保署 |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/61595 |
作者单位 | 1.NIEHS, Natl Toxicol Program, Interagency Ctr Evaluat Alternat Toxicol Methods, POB 12233, Res Triangle Pk, NC 27709 USA; 2.Phys Comm Responsible Med, Washington, DC USA; 3.Integrated Lab Syst Inc, Res Triangle Pk, NC USA; 4.US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; 5.US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; 6.ILSI Hlth & Environm Sci Inst, Washington, DC USA; 7.US Consumer Prod Safety Commiss, Rockville, MD USA; 8.Dow Chem Co USA, Midland, MI 48674 USA; 9.Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy |
推荐引用方式 GB/T 7714 | Kleinstreuer, Nicole C.,Sullivan, Kristie,Allen, David,et al. Adverse outcome pathways: From research to regulation scientific workshop report[J]. 美国环保署,2016,76:39-50. |
APA | Kleinstreuer, Nicole C..,Sullivan, Kristie.,Allen, David.,Edwards, Stephen.,Mendrick, Donna L..,...&Casey, Warren.(2016).Adverse outcome pathways: From research to regulation scientific workshop report.REGULATORY TOXICOLOGY AND PHARMACOLOGY,76,39-50. |
MLA | Kleinstreuer, Nicole C.,et al."Adverse outcome pathways: From research to regulation scientific workshop report".REGULATORY TOXICOLOGY AND PHARMACOLOGY 76(2016):39-50. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。